These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16598752)

  • 21. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone.
    Sibonga JD; Bell NH; Turner RT
    J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Less-calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in rat skeletal tissues.
    Somjen D; Posner GH; Weisman Y; Kaye AM
    J Endocrinol Invest; 2007 Feb; 30(2):91-6. PubMed ID: 17392597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hormonal milieu in early stages of bone cell differentiation modifies the subsequent sex-specific responsiveness of the developing bone to gonadal steroids.
    Berger E; Bleiberg I; Weisman Y; Lifschitz-Mercer B; Leider-Trejo L; Harel A; Kaye AM; Somjen D
    J Bone Miner Res; 2001 May; 16(5):823-31. PubMed ID: 11341327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
    Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
    Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DT56a stimulates creatine kinase specific activity in vascular tissues of rats.
    Somjen D; Yoles I
    J Endocrinol Invest; 2003 Oct; 26(10):966-71. PubMed ID: 14759068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with raloxifene and 17beta-estradiol differentially modulates nitric oxide and prostanoids in venous endothelium and platelets of ovariectomized pigs.
    Lewis DA; Avsar M; Labreche P; Bracamonte M; Jayachandran M; Miller VM
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):231-8. PubMed ID: 17110805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic treatments with the low-calcemic 1,25(OH)(2)D(3) analogs JKF or QW increase both the morphological and biochemical responses to estradiol-17beta in rat tibiae.
    Somjen D; Katzburg S; Posner GH; Livne E; Kaye AM
    J Cell Biochem; 2007 Apr; 100(6):1406-14. PubMed ID: 17163482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of raloxifene in immature and ovariectomized rat uterotrophic assays.
    Ashby J; Odum J; Foster JR
    Regul Toxicol Pharmacol; 1997 Jun; 25(3):226-31. PubMed ID: 9237325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of diabetes on creatine kinase activity in streptozotocin-diabetic rats.
    Zhao X; Bassirat M; Zeinab K; Helme RD
    Chin Med J (Engl); 1999 Nov; 112(11):1028-31. PubMed ID: 11721466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene plus 17beta-estradiol inhibits proliferation of primary cultured vascular smooth muscle cells and human mammary endothelial cells via the janus kinase/signal transducer and activator of transcription3 cascade.
    Wang TH; Xiang QL; Chen JW; Pan H; Cui YH
    Eur J Pharmacol; 2007 Apr; 561(1-3):7-13. PubMed ID: 17336289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
    Savolainen-Peltonen H; Luoto NM; Kangas L; Häyry P
    Mol Cell Endocrinol; 2004 Nov; 227(1-2):9-20. PubMed ID: 15501580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene.
    Helvering LM; Liu R; Kulkarni NH; Wei T; Chen P; Huang S; Lawrence F; Halladay DL; Miles RR; Ambrose EM; Sato M; Ma YL; Frolik CA; Dow ER; Bryant HU; Onyia JE
    Mol Pharmacol; 2005 Nov; 68(5):1225-38. PubMed ID: 16079270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats.
    Esposito E; Iacono A; Raso GM; Pacilio M; Coppola A; Di Carlo R; Meli R
    Endocrinology; 2005 Aug; 146(8):3301-8. PubMed ID: 15860553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Non-hypercalcemic" analogs of 1alpha,25 dihydroxy vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs.
    Somjen D; Waisman A; Weisman Y; Kaye AM
    J Steroid Biochem Mol Biol; 2000; 72(1-2):79-88. PubMed ID: 10731641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
    Okano H; Jayachandran M; Yoshikawa A; Miller VM
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):621-8. PubMed ID: 16680078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
    Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
    J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-idiotypic antibody as an oestrogen mimetic in vivo: stimulation of creatine kinase specific activity in rat animal models.
    Sömjen D; Amir-Zaltsman Y; Mor G; Gayer B; Lichter S; Barnard G; Kohen F
    J Endocrinol; 1996 May; 149(2):305-12. PubMed ID: 8708542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.